Adding Darolutamide Ups Survival in Metastatic Prostate Cancer
Risk for death lower with darolutamide versus placebo, combined with androgen-deprivation therapy and docetaxel
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.